Syndax Pharmaceuticals Inc reports results for the quarter ended in September - Earnings Summary

Syndax Pharmaceuticals

02/11/2023 21:03

* Syndax Pharmaceuticals Inc  SNDX.OQ  reported a quarterly
adjusted loss of 73 cents​​ per share for the quarter ended in
September, lower than the same quarter last year, when the
company reported EPS of -58 cents.  The mean expectation of
eleven analysts for the quarter was for a loss of 80 cents per
share. Wall Street expected results to range from -87 cents
to -75 cents per share.
    * Reported revenue was zero​; analysts expected zero. 
    * Syndax Pharmaceuticals Inc's reported EPS for the quarter
was a
loss of 73 cents​.
    * The company reported a quarterly loss of $51.15 million.
    * Syndax Pharmaceuticals Inc shares had fallen by 4.1% this
quarter and lost 45.3% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had fallen by
about 0.8%
in the last three months.​ 
    * In the last 30 days, one analyst negatively revised an
earnings
estimate

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 13 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
    * Wall Street's median 12-month price target for Syndax
Pharmaceuticals Inc is $36.00 

This summary was machine generated from LSEG data November 2 at
09:02 p.m. UTC. ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2023      -0.80          -0.73          Beat
 Jun. 30 2023      -0.73          -0.64          Beat
 Mar. 31 2023      -0.60          -0.59          Beat
 Dec. 31 2022      -0.65          -0.62          Beat